Research
Title : | A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects with Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis |
Area of research : | Life Sciences & Biotechnology, Medical Sciences |
Focus area : | Chronic Diseases |
Principal Investigator : | Dr Shalimar, Associate Professor, All India Institute of Medical Sciences (AIIMS), New Delhi |
Timeline Start Year : | 2017 |
Timeline End Year : | 2022 |
Contact info : | drshalimar@yahoo.com |
Details
Total Budget (INR): | 10,00,000 |
Organizations involved
Implementing Agency : | All India Institute of Medical Sciences (AIIMS), New Delhi Funding Agency :Gilead Sciences, Inc., USA | |